Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models.
Hvid H, Brand CL, Hummelshøj T, Jensen S, Bouman SD, Bowler A, Poulsen BR, Tiainen P, Åkertröm T, Demozay D, Hoeg-Jensen T, Ingvorsen C, Pedersen TÅ, McGuire J, Egebjerg T, Cappelen KA, Eliasen IP, Hansen BF, Hennen S, Stidsen CE, Olsen GS, Roed NK.
Hvid H, et al. Among authors: demozay d.
Diabetologia. 2023 Feb;66(2):376-389. doi: 10.1007/s00125-022-05828-w. Epub 2022 Nov 21.
Diabetologia. 2023.
PMID: 36404376
Free PMC article.